Fresenius Medical Care

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$4,760,162
$4,766,438
$4,725,000
$4,988,000
Gross Profit
1,146,084
1,166,489
1,174,000
1,350,000
EBITDA
845,886
736,457
729,000
880,446
EBIT
479,630
349,457
341,265
478,016
Net Income
213,027
187,000
70,959
187,925
Net Change In Cash
4,760,162
4,766,438
4,725,000
4,988,000
Free Cash Flow
1,101,774
277,236
-6,592
468,788
Cash
1,370,890
1,090,000
1,148,000
1,403,492
Basic Shares
534,170
293,413
586,826
293,413

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$19,453,617
$19,398,000
$17,619,000
$17,859,000
Gross Profit
4,924,617
5,310,000
5,077,000
5,537,000
EBITDA
3,209,626
1,580,000
3,549,136
4,132,267
EBIT
1,457,655
-140,135
1,963,769
2,545,398
Net Income
498,997
673,405
969,308
1,164,377
Net Change In Cash
19,453,617
19,398,000
17,619,000
17,859,000
Free Cash Flow
1,944,205
756,000
806,000
2,145,000
Cash
1,403,492
1,273,787
1,481,655
1,081,539
Basic Shares
293,413
293,246
293,065
294,278

Earnings Calls

Quarter EPS
2024-09-30
$0.39
2024-06-30
$0.24
2024-03-31
$0.41
2023-12-31
$0.44